Listed

Tandem Diabetes Care Inc

TNDMNasdaqCIK 1438133HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$254.6mRevenue, Q2 FY2026, three months to 2026-06-30$254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 6, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$254.6mRevenue, Q2 FY2026, three months to 2026-06-30$254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure+5.8% on a year earlier
  • Gross margin56.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $144.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure+4.6 pts on a year earlier
  • Operating margin−5.4%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure+16.1 pts on a year earlier
  • Net margin−8.3%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure+13.5 pts on a year earlier
  • Diluted EPS−$0.31Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure+60.3% on a year earlier
  • Free cash flow−$38.7mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$34.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001438133-26-000125. Derived: 6-month figure less the 3-month figure.Capital expenditure: $4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001438133-26-000125. Derived: 6-month figure less the 3-month figure.Report this figure−146.3% on a year earlier

Last eight quarters

Full statements
Revenue$254.6mGross margin 56.9%
Diluted EPS−$0.31, Q2 FY2026
Free cash flow−$38.7m, Q2 FY2026
Tandem Diabetes Care Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m244Revenue, Q3 FY2024, three months to 2024-09-30$244.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure283Revenue, Q4 FY2024, three months to 2024-12-31$282.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure234Revenue, Q1 FY2025, three months to 2025-03-31$234.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure241Revenue, Q2 FY2025, three months to 2025-06-30$240.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure249Revenue, Q3 FY2025, three months to 2025-09-30$249.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure290Revenue, Q4 FY2025, three months to 2025-12-31$290.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure247Revenue, Q1 FY2026, three months to 2026-03-31$247.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure255Revenue, Q2 FY2026, three months to 2026-06-30$254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure
Gross margin%51.1%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $124.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Revenue: $244.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure55.7%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $157.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $282.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure50.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $118.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Revenue: $234.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure52.3%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $125.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $240.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure53.9%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $134.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Revenue: $249.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure57.7%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $167.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $290.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure55.3%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $136.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Revenue: $247.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure56.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $144.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure
Operating margin%(10.7%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$26.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Revenue: $244.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure(0.2%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$581.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $282.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(51.6%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$120.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Revenue: $234.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(21.5%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$51.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $240.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure(9.2%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Revenue: $249.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure2.9%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $290.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(7.1%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$17.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Revenue: $247.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(5.4%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure
Net margin%(9.5%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Revenue: $244.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure0.3%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $755.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $282.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(55.7%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$130.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Revenue: $234.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(21.8%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$52.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $240.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure(8.5%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Revenue: $249.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure(0.2%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$589.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $290.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(8.2%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$20.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Revenue: $247.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(8.3%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Revenue: $254.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure
Diluted EPS$ per share(0.35)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure0.01Diluted EPS, Q4 FY2024, three months to 2024-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(1.97)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(0.78)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure(0.31)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001438133-25-000187.Report this figure(0.01)Diluted EPS, Q4 FY2025, three months to 2025-12-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(0.30)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(0.31)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001438133-26-000125.Report this figure
Free cash flow$m21.5Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $26.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001438133-25-000187. Derived: 9-month figure less the 6-month figure.Capital expenditure: $5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001438133-25-000187. Derived: 9-month figure less the 6-month figure.Report this figure7.6Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438133-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001438133-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(21.2)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Capital expenditure: $3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(15.7)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001438133-26-000125. Derived: 6-month figure less the 3-month figure.Capital expenditure: $6.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001438133-26-000125. Derived: 6-month figure less the 3-month figure.Report this figure4.2Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001438133-25-000187. Derived: 9-month figure less the 6-month figure.Capital expenditure: $4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001438133-25-000187. Derived: 9-month figure less the 6-month figure.Report this figure3.1Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438133-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $6.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001438133-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure4.8Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $11.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Capital expenditure: $6.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001438133-26-000049.Report this figure(38.7)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$34.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001438133-26-000125. Derived: 6-month figure less the 3-month figure.Capital expenditure: $4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001438133-26-000125. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.01bnGross margin 53.8%
Diluted EPS−$3.04, FY2025
Free cash flow−$29.7m, FY2025
Tandem Diabetes Care Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m703Revenue, FY2021, twelve months to 2021-12-31$702.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-21, accession 0001438133-24-000028.Report this figure801Revenue, FY2022, twelve months to 2022-12-31$801.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001438133-25-000036.Report this figure748Revenue, FY2023, twelve months to 2023-12-31$747.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure940Revenue, FY2024, twelve months to 2024-12-31$940.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure1,015Revenue, FY2025, twelve months to 2025-12-31$1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure
Gross margin%53.5%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $376.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-21, accession 0001438133-24-000028.Revenue: $702.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-21, accession 0001438133-24-000028.Report this figure51.5%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $413.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-26, accession 0001438133-25-000036.Revenue: $801.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001438133-25-000036.Report this figure49.2%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $367.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $747.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure52.1%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $489.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $940.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure53.8%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $546.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure
Operating margin%3.2%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $22.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-21, accession 0001438133-24-000028.Revenue: $702.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-21, accession 0001438133-24-000028.Report this figure(11.6%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$92.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-26, accession 0001438133-25-000036.Revenue: $801.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001438133-25-000036.Report this figure(31.2%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$233.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $747.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(10.5%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$99.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $940.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(18.5%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$187.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure
Net margin%2.2%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-21, accession 0001438133-24-000028.Revenue: $702.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-21, accession 0001438133-24-000028.Report this figure(11.8%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$94.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-26, accession 0001438133-25-000036.Revenue: $801.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001438133-25-000036.Report this figure(29.8%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$222.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $747.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(10.2%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$96.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $940.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(20.2%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$204.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001438133-26-000010.Revenue: $1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure
Diluted EPS$ per share0.24Diluted EPS, FY2021, twelve months to 2021-12-31$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-21, accession 0001438133-24-000028.Report this figure(1.47)Diluted EPS, FY2022, twelve months to 2022-12-31−$1.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-26, accession 0001438133-25-000036.Report this figure(3.43)Diluted EPS, FY2023, twelve months to 2023-12-31−$3.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(1.47)Diluted EPS, FY2024, twelve months to 2024-12-31−$1.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(3.04)Diluted EPS, FY2025, twelve months to 2025-12-31−$3.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure
Free cash flow$m97.2Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $111.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-21, accession 0001438133-24-000028.Capital expenditure: $14.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-21, accession 0001438133-24-000028.Report this figure16.4Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $50.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-26, accession 0001438133-25-000036.Capital expenditure: $34.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-26, accession 0001438133-25-000036.Report this figure(58.6)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$31.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438133-26-000010.Capital expenditure: $26.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure5.0Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $24.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438133-26-000010.Capital expenditure: $19.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure(29.7)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438133-26-000010.Capital expenditure: $19.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001438133-26-000010.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

By month, by reported value, last 24 monthsPurchases $0Sales $32.6k
Tandem Diabetes Care Inc, open-market insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-27Twomey Christopher JDirector Sale1,700$19.15$32.6kForm 4

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Tandem Diabetes Care Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$174.8m11,583,125Added+892,281
UBS Group AG2026-06-30$78.1m5,178,570CallUnchanged
Sessa Capital IM, L.P.2026-06-30$77.0m5,100,000Added+369,243
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$64.9m4,299,667Added+306,334
First Light Asset Management, LLC2026-06-30$51.1m3,383,553Added+2,068,838
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$46.7m3,096,536Added+57,617
STATE STREET CORP2026-06-30$43.0m2,851,646Added+189,386
JENNISON ASSOCIATES LLC2026-06-30$35.2m2,331,429Added+672,981
Paradice Investment Management LLC2026-06-30$30.5m2,024,014Reduced−18,411
JACOBS LEVY EQUITY MANAGEMENT, INC2026-06-30$30.3m2,006,429Added+482,483

Recent filings

All 1,251 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Tandem Diabetes Care Inc, recent filings
FiledFormWhat it isAccession number
2026-08-0616:11 ET10-QQuarterly reportPeriod 2026-06-300001438133-26-000125
2026-08-0616:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001438133-26-000124
2026-05-2116:10 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001438133-26-000070
2026-05-1507:59 ET8-K5.02 Departure or appointment of officers or directors0001438133-26-000052
2026-05-0716:06 ET10-QQuarterly reportPeriod 2026-03-310001438133-26-000049
2026-05-0716:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001438133-26-000048
2026-04-0716:23 ETDEF 14AProxy statementPeriod 2025-12-310001438133-26-000034
2026-02-2716:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-26-007142
2026-02-1916:09 ET10-KAnnual reportPeriod 2025-12-310001438133-26-000010
2026-02-1916:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001438133-26-000009

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 19, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1438133
Tickers
TNDM
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.